Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 9 (3) , 223-229
- https://doi.org/10.1016/s1053-4296(99)80013-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trialEuropean Journal Of Cancer, 1992
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.Journal of Clinical Oncology, 1990
- Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?Cancer, 1990
- West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodesBritish Journal of Cancer, 1989
- Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.Journal of Clinical Oncology, 1988
- Adjuvant radiotherapy and chemotherapy in breast cancerBritish Journal of Surgery, 1986
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCERThe Lancet, 1983
- A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapyAmerican Journal of Clinical Oncology, 1982